Impact of glycemic control on aortic stiffness, left ventricular mass and diastolic longitudinal function in type 2 diabetes mellitus

Cardiovascular Diabetology

Volumn 16, Issue 1, 2017, Pages

  Kozakova, Michaela ^a,b   Morizzo, Carmela ^a   Fraser, Alan G ^c   Palombo, Carlo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Esaote   (Italy)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Aortic stiffness; Arterio ventricular coupling; Glycemic control; LV diastolic function; LV mass; Systodiastolic coupling

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGE; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY SIZE; CAROTID ARTERY FLOW; CONTROLLED STUDY; DIASTOLE; DYSLIPIDEMIA; FEMALE; FEMORAL ARTERY FLOW; GLYCEMIC CONTROL; HEART FUNCTION; HEART LEFT VENTRICLE MASS; HEART RATE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART WORK; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; PREVALENCE; PULSE WAVE; SEX; SYSTOLE; SYSTOLIC BLOOD PRESSURE; VOLUNTEER; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COLOR DOPPLER ECHOCARDIOGRAPHY; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETIC ANGIOPATHY; DIABETIC CARDIOMYOPATHY; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART STROKE VOLUME; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PULSED DOPPLER ECHOCARDIOGRAPHY; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; HYPOGLYCEMIC AGENTS; LINEAR MODELS; MALE; MIDDLE AGED; MITRAL VALVE; MULTIVARIATE ANALYSIS; PULSE WAVE ANALYSIS; RISK FACTORS; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VASCULAR STIFFNESS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 85027590313     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-017-0557-z     Document Type: Article

References (49)

1. Bibra H, Sutton MSJ. Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis. Diabetologia 2010; 53: 1033-1045. 10.1007/s00125-010-1682-3
2. Stratmann B, Tscoepe D. Heart in diabetes: not only a macrovascular disease. Diabetes Care 2011; 34(Suppl 2): S138-S144. 10.2337/dc11-s2083632151
3. Sánchez-Barriga JJ, Rangel A, Castañeda R, Flores D, Frati AC, Ramos MA. Left ventricular diastolic dysfunction secondary to hyperglycemia in patients with type II diabetes. Arch Med Res 2001; 32: 44-47. 10.1016/S0188-4409(00)00264-2
4. MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, CHARM Investigators. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J 2008; 29: 1377-1385. 10.1093/eurheartj/ehn153
5. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001; 103: 2668-2673. 10.1161/01.CIR.103.22.2668
6. Tsujino T, Kawasaki D, Masuyama T. Left ventricular diastolic dysfunction in diabetic patients: pathophysiology and therapeutic implications. Am J Cardiovasc Drugs 2006; 6: 219-230. 10.2165/00129784-200606040-00002
7. Feng B, Chen S, Chiu J, George B, Chakrabarti S. Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. Am J Physiol Endocrinol Metab 2008; 294: E1119-E1126. 10.1152/ajpendo.00029.2008
8. Monnier VM, Sell DR, Abdul-Karim FW, Emancipator SN. Collagen browning and cross-linking are increased in chronic experimental hyperglycemia. Relevance to diabetes and aging. Diabetes 1988; 37: 867-872. 10.2337/diab.37.7.867
9. Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008; 117: 43-51. 10.1161/CIRCULATIONAHA.107.728550
10. Xie J, Cui K, Hao H, Zhang Y, Lin H, Chen Z, Huang X, Cao S, Liao W, Bin J, Kitakaze M, Liao Y. Acute hyperglycemia suppresses left ventricular diastolic function and inhibits autophagic flux in mice under prohypertrophic stimulation. Cardiovasc Diabetol 2016; 15: 136. 10.1186/s12933-016-0452-z5034479
11. Gao X, Xu Y, Xu B, Liu Y, Cai J, Liu HM, Lei S, Zhong YQ, Irwin MG, Xia Z. Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes. Diabetes Metab Res Rev 2012; 28: 409-417. 10.1002/dmrr.2295
12. Reddy GK. AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc Res 2004; 68: 132-142. 10.1016/j.mvr.2004.04.002
13. Leite-Moreira AF, Correia-Pinto J, Gillebert TC. Afterload induced changes in myocardial relaxation: a mechanism for diastolic dysfunction. Cardiovasc Res 1999; 43: 344-353. 10.1016/S0008-6363(99)00099-1
14. Gillebert TC, Lew WYW. Influence of systolic pressure profile on rate of left ventricular pressure fall. Am J Physiol 1991; 261: H805-H813
15. Flachskampf FA, Biering-Sørensen T, Solomon SD, Duvernoy O, Bjerner T, Smiseth OA. Cardiac imaging to evaluate left ventricular diastolic function. JACC Cardiovasc Imaging 2015; 8: 1071-1093. 10.1016/j.jcmg.2015.07.004
16. Opdahl A, Remme EW, Helle-Valle T, Lyseggen E, Vartdal T, Pettersen E. Determinants of left ventricular early-diastolic lengthening velocity: independent contributions from left ventricular relaxation, restoring forces, and lengthening load. Circulation 2009; 119: 2578-2586. 10.1161/CIRCULATIONAHA.108.791681
17. Kosmala W, Przewlocka-Kosmala M, Wojnalowicz A, Mysiak A, Marwick TH. Integrated backscatter as a fibrosis marker in the metabolic syndrome: association with biochemical evidence of fibrosis and left ventricular dysfunction. Eur Heart J Cardiovasc Imaging 2012; 13: 459-467. 10.1093/ejechocard/jer291
18. Querejeta R, Varo N, López B, Larman M, Artiñano E, Etayo JC. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation 2000; 101: 1729-1735. 10.1161/01.CIR.101.14.1729
19. Patil VC, Patil HV, Shah KB, Vasani JD, Shetty P. Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function. J Cardiovasc Dis Res. 2011; 2: 213-222. 10.4103/0975-3583.898053224441
20. Bibra H, Paulus WJ, Sutton MSJ, Leclerque C, Schuster T, Schumm-Draeger PM. Quantification of diastolic dysfunction via the age dependence of diastolic function-impact of insulin resistance with and without type 2 diabetes. Int J Cardiol 2015; 182: 368-374. 10.1016/j.ijcard.2014.12.005
21. Leung M, Wong VW, Hudson M, Leung DY. Impact of improved glycemic control on cardiac function in type 2 diabetes mellitus. Circ Cardiovasc Imaging 2016; 9: e003643. 10.1161/CIRCIMAGING.115.003643
22. Weber T, O'Rourke MF, Ammer M, Kvas E, Punzengruber C, Eber B. Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction. Am J Hypertens 2008; 21: 1194-1202. 10.1038/ajh.2008.277
23. Borges MC, Colombo RC, Gonçalves JG, Oliveira Ferreira J, Franchini KG. Longitudinal mitral annulus velocities are reduced in hypertensive subjects with or without left ventricle hypertrophy. Hypertension 2006; 47: 854-860. 10.1161/01.HYP.0000216123.57284.b0
24. Hills SA, Balkau B, Coppack SW, Dekker JM, Mari A, Natali A. The EGIR-RISC Study (The European group for the study of insulin resistance; relationship between insulin sensitivity and cardiovascular risk): I. Methodology and objectives. Diabetologia 2004; 47: 566-570. 10.1007/s00125-004-1335-5
25. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1-39. 10.1016/j.echo.2014.10.003
26. Sharifov OF, Schiros CG, Aban I, Denney TS, Gupta H. Diagnostic accuracy of tissue Doppler index e/e' for evaluating left ventricular filling pressure and diastolic dysfunction/heart failure with preserved ejection fraction: a systematic review and meta-analysis. J Am Heart Assoc 2016; 5: 1-6. 10.1161/JAHA.115.002530
27. American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care 2016; 39(Suppt 1): S13-S22
28. Mattace-Raso F, Hofman A, Verwoert GC, Wittemana JC, Wilkinson I, Cockcroft J. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: establishing normal and reference values. Eur Heart J 2010; 31: 2338-2350. 10.1093/eurheartj/ehq165
29. Palombo C, Kozakova M, Guraschi N, Bini G, Cesana F, Castoldi G. Radiofrequency-based carotid wall tracking: a comparison between two different systems. J Hypertens 2012; 30: 1614-1619. 10.1097/HJH.0b013e328354dd44
30. Bramwell JC, Hill AV. The velocity of the pulse wave in man. Proc R Soc Lond B 1922; 93: 298-306. 10.1098/rspb.1922.0022
31. Bortel LM, Balkestein EJ, Heijden-Spek JJ, Vanmolkot FH, Staessen JA, Kragten JA. Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens 2001; 19: 1037-1044. 10.1097/00004872-200106000-00007
32. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458. 10.1016/0002-9149(86)90771-X
33. Simone G, Verdecchia P, Pede S, Gorini M, Maggioni AP. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension 2002; 40: 470-476. 10.1161/01.HYP.0000034740.99323.8A
34. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 2000; 101: 2271-2276. 10.1161/01.CIR.101.19.2271
35. Chahal NS, Lim TK, Jain P, Chambers JC, Kooner JS, Senior R. Normative reference values for tissue Doppler imaging parameters of left ventricular function: a population-based study. Eur J Echocardiogr 2010; 11: 51-56. 10.1093/ejechocard/jep164
36. Sciacqua A, Miceli S, Carullo G, Greco L, Succurro E, Arturi F. One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 2011; 34: 1406-1411. 10.2337/dc11-01553114345
37. Felicio JS, Pacheco JT, Ferreira SR, Plavnik F, Moisés VA, Kohlmann OJr. Hyperglycemia and nocturnal systolic blood pressure are associated with left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients. Cardiovasc Diabetol 2006; 5: 19. 10.1186/1475-2840-5-191579206
38. Striker LJ, Striker GE. Administration of AGEs in vivo induces extracellular matrix gene expression. Nephrol Dial Transplant 1996; 11(Suppl 5): 62-65. 10.1093/ndt/11.supp5.62
39. Wang CC, Wang YC, Wang GJ, Shen MY, Chang YL, Liou SY. Skin autofluorescence is associated with inappropriate left ventricular mass and diastolic dysfunction in subjects at risk for cardiovascular disease. Cardiovasc Diabetol 2017; 16: 15-25. 10.1186/s12933-017-0495-95267439
40. Borbély A, Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ. Cardiomyocyte stiffness in diastolic heart failure. Circulation 2005; 111: 774-781. 10.1161/01.CIR.0000155257.33485.6D
41. Ferreira MT, Leite NC, Cardoso CR, Salles GF. Correlates of aortic stiffness progression in patients with type 2 diabetes: importance of glycemic control: the Rio de Janeiro type 2 diabetes cohort study. Diabetes Care 2015; 38: 897-904. 10.2337/dc14-2791
42. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012; 308: 875-881. 10.1001/2012.jama.105033594687
43. Kozakova M, Morizzo C, Guarino D, Federico G, Miccoli M, Giannattasio C. The impact of age and risk factors on carotid and carotid-femoral pulse wave velocity. J Hypertens 2015; 33: 1446-1451
44. Paini A, Boutouyrie P, Calvet D, Tropeano AI, Laloux B, Laurent S. Carotid and aortic stiffness: determinants of discrepancies. Hypertension 2006; 47: 371-376. 10.1161/01.HYP.0000202052.25238.68
45. Novo G, Manno G, Russo R, Buccheri D, Dell'Oglio S, Morreale P. Impact of insulin resistance on cardiac and vascular function. Int J Cardiol 2016; 221: 1095-1099. 10.1016/j.ijcard.2016.07.087
46. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, Romijn JA, Roos A, Radder JK. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003; 42: 328-335. 10.1016/S0735-1097(03)00625-9
47. Rijzewijk LJ, Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008; 52: 1793-1799. 10.1016/j.jacc.2008.07.062
48. Dimitropoulos G, Tahrani AA, Stevens MJ. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes 2014; 5: 17-39. 10.4239/wjd.v5.i1.173932425
49. Grandi AM, Piantanida E, Franzetti I, Bernasconi M, Maresca A, Marnini P. Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus. Am J Cardiol 2006; 97: 71-76. 10.1016/j.amjcard.2005.07.110